Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre M G Bouloux

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Endocrinology and Metabolism: TEM|March 15, 2002
GnRH neuronal development: insights into hypogonadotrophic hypogonadismGavin MacColl, Richard Quinton, Pierre M G Bouloux
Seminars in Reproductive Medicine|January 22, 2003
Hypogonadotropic hypogonadismLeticia F G Silveira, Gavin S MacColl, Pierre M G Bouloux
Journal of Molecular Biology|June 14, 2005
Extended and flexible domain solution structure of the extracellular matrix protein anosmin-1 by X-ray scattering, analytical ultracentrifugation and constrained modellingYouli Hu, Zhe Sun, Julian T Eaton, et al.
The American Journal of Medicine|September 5, 2002
Growth hormone therapy for non-islet cell tumor hypoglycemiaLetícia F G Silveira, Pierre M G Bouloux, Gavin S MacColl, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 19, 2008
Serum IGF-I levels and IGF-I gene splicing in muscle of healthy young males receiving rhGHMichael Aperghis, Cristiana P Velloso, Mahjabeen Hameed, et al.
European Journal of Endocrinology|February 13, 2009
Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled studyJean-Jacques Legros, Eric J H Meuleman, Jolanda M H Elbers, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|April 16, 2013
Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging studyPierre M G Bouloux, Jean-Jacques Legros, Jolanda M H Elbers, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|June 2, 2015
Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadismEric J H Meuleman, Jean-Jacques Legros, Pierre M G Bouloux, et al.
Pituitary|March 5, 2025
Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statementNicola Newall, Alexandra Valetopoulou, Danyal Z Khan, et al.
Pituitary|July 23, 2025
A core outcome set for pituitary surgery research: an international delphi consensus studyAlexandra Valetopoulou, Nicola Newall, Danyal Z Khan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Endocrinology and Metabolism: TEM|March 15, 2002
GnRH neuronal development: insights into hypogonadotrophic hypogonadismGavin MacColl, Richard Quinton, Pierre M G Bouloux
Seminars in Reproductive Medicine|January 22, 2003
Hypogonadotropic hypogonadismLeticia F G Silveira, Gavin S MacColl, Pierre M G Bouloux
Journal of Molecular Biology|June 14, 2005
Extended and flexible domain solution structure of the extracellular matrix protein anosmin-1 by X-ray scattering, analytical ultracentrifugation and constrained modellingYouli Hu, Zhe Sun, Julian T Eaton, et al.
The American Journal of Medicine|September 5, 2002
Growth hormone therapy for non-islet cell tumor hypoglycemiaLetícia F G Silveira, Pierre M G Bouloux, Gavin S MacColl, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 19, 2008
Serum IGF-I levels and IGF-I gene splicing in muscle of healthy young males receiving rhGHMichael Aperghis, Cristiana P Velloso, Mahjabeen Hameed, et al.
European Journal of Endocrinology|February 13, 2009
Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled studyJean-Jacques Legros, Eric J H Meuleman, Jolanda M H Elbers, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|April 16, 2013
Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging studyPierre M G Bouloux, Jean-Jacques Legros, Jolanda M H Elbers, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|June 2, 2015
Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadismEric J H Meuleman, Jean-Jacques Legros, Pierre M G Bouloux, et al.
Pituitary|March 5, 2025
Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statementNicola Newall, Alexandra Valetopoulou, Danyal Z Khan, et al.
Pituitary|July 23, 2025
A core outcome set for pituitary surgery research: an international delphi consensus studyAlexandra Valetopoulou, Nicola Newall, Danyal Z Khan, et al.
Pageof 1